209 related articles for article (PubMed ID: 9045658)
1. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor.
Shimomura T; Denda K; Kitamura A; Kawaguchi T; Kito M; Kondo J; Kagaya S; Qin L; Takata H; Miyazawa K; Kitamura N
J Biol Chem; 1997 Mar; 272(10):6370-6. PubMed ID: 9045658
[TBL] [Abstract][Full Text] [Related]
2. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
[TBL] [Abstract][Full Text] [Related]
3. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator.
Shimomura T; Miyazawa K; Komiyama Y; Hiraoka H; Naka D; Morimoto Y; Kitamura N
Eur J Biochem; 1995 Apr; 229(1):257-61. PubMed ID: 7744037
[TBL] [Abstract][Full Text] [Related]
4. Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.
Shimomura T; Denda K; Kawaguchi T; Matsumoto K; Miyazawa K; Kitamura N
J Biochem; 1999 Nov; 126(5):821-8. PubMed ID: 10544273
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII.
Miyazawa K; Shimomura T; Kitamura A; Kondo J; Morimoto Y; Kitamura N
J Biol Chem; 1993 May; 268(14):10024-8. PubMed ID: 7683665
[TBL] [Abstract][Full Text] [Related]
8. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
9. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2.
Qin L; Denda K; Shimomura T; Kawaguchi T; Kitamura N
FEBS Lett; 1998 Sep; 436(1):111-4. PubMed ID: 9771903
[TBL] [Abstract][Full Text] [Related]
13. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
Kojima K; Tsuzuki S; Fushiki T; Inouye K
J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
[TBL] [Abstract][Full Text] [Related]
14. Activation of the zymogen of hepatocyte growth factor activator by thrombin.
Shimomura T; Kondo J; Ochiai M; Naka D; Miyazawa K; Morimoto Y; Kitamura N
J Biol Chem; 1993 Oct; 268(30):22927-32. PubMed ID: 8226803
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
16. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.
Kataoka H; Miyata S; Uchinokura S; Itoh H
Cancer Metastasis Rev; 2003; 22(2-3):223-36. PubMed ID: 12784998
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation.
Lee YR; Yamazaki M; Mitsui S; Tsuboi R; Ogawa H
J Dermatol Sci; 2001 Feb; 25(2):156-63. PubMed ID: 11164712
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.
Miyazawa K
FEBS J; 2010 May; 277(10):2208-14. PubMed ID: 20402766
[TBL] [Abstract][Full Text] [Related]
20. Induction of hepatocyte growth factor activator messenger RNA in the liver following tissue injury and acute inflammation.
Okajima A; Miyazawa K; Naitoh Y; Inoue K; Kitamura N
Hepatology; 1997 Jan; 25(1):97-102. PubMed ID: 8985272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
